These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


733 related items for PubMed ID: 23573557

  • 1. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S, Poston G.
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [Abstract] [Full Text] [Related]

  • 2. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [Abstract] [Full Text] [Related]

  • 3. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
    Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H.
    Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.
    Wein A, Riedel C, Brückl W, Merkel S, Ott R, Hanke B, Baum U, Fuchs F, Günther K, Reck T, Papadopoulos T, Hahn EG, Hohenberger W.
    Oncology; 2003 Oct; 64(2):131-8. PubMed ID: 12566910
    [Abstract] [Full Text] [Related]

  • 5. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
    Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H.
    Ann Surg; 2004 Dec; 240(6):1052-61; discussion 1061-4. PubMed ID: 15570210
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
    Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, Brienza S, Alafaci E, Bertheault-Cvitkovic F, Jasmin C, Reynes M, Bismuth H, Misset JL, Lévi F.
    Ann Oncol; 1999 Jun; 10(6):663-9. PubMed ID: 10442188
    [Abstract] [Full Text] [Related]

  • 7. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [Abstract] [Full Text] [Related]

  • 9. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.
    BMC Cancer; 2018 Aug 06; 18(1):787. PubMed ID: 30081865
    [Abstract] [Full Text] [Related]

  • 10. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.
    Ji JH, Park SH, Lee J, Kim TW, Hong YS, Kim KP, Kim SY, Baek JY, Kang HJ, Shin SJ, Shim BY, Park YS.
    Cancer Chemother Pharmacol; 2013 Jul 06; 72(1):223-30. PubMed ID: 23689915
    [Abstract] [Full Text] [Related]

  • 11. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
    Frena A, Martin F, La Guardia G, Vezzali N, Bonatti G, Stocker J, Graiff C.
    Chir Ital; 2004 Jul 06; 56(3):351-7. PubMed ID: 15287631
    [Abstract] [Full Text] [Related]

  • 12. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI, Kotelnikov AG, Mamontov KG, Podluzhny DV, Ponomarenko AA.
    Vopr Onkol; 2015 Jul 06; 61(3):439-47. PubMed ID: 26242159
    [Abstract] [Full Text] [Related]

  • 13. Regional chemotherapy for liver-limited metastatic colorectal cancer.
    Power DG, Healey-Bird BR, Kemeny NE.
    Clin Colorectal Cancer; 2008 Jul 06; 7(4):247-59. PubMed ID: 18650193
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A.
    Med Sci Monit; 2010 Feb 06; 16(2):CR49-55. PubMed ID: 20110914
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
    Sato Y, Inaba Y, Ura T, Nishiofuku H, Yamaura H, Kato M, Takahari D, Tanaka T, Muro K.
    J Gastrointest Cancer; 2018 Jun 06; 49(2):132-137. PubMed ID: 28058527
    [Abstract] [Full Text] [Related]

  • 16. Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.
    Garufi C, Torsello A, Tumolo S, Ettorre GM, Zeuli M, Campanella C, Vennarecci G, Mottolese M, Sperduti I, Cognetti F.
    Br J Cancer; 2010 Nov 09; 103(10):1542-7. PubMed ID: 20959822
    [Abstract] [Full Text] [Related]

  • 17. Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.
    Takahashi T, Shibata Y, Tojima Y, Tsuboi K, Sakamoto E, Kunieda K, Matsuoka H, Suzumura K, Sato M, Naganuma T, Sakamoto J, Morita S, Kondo K.
    Int J Clin Oncol; 2013 Apr 09; 18(2):335-42. PubMed ID: 22383023
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR, Min BS, Kim JS, Shin SJ, Ahn JB, Rho JK, Kim NK, Rha SY.
    Oncology; 2011 Apr 09; 81(3-4):175-83. PubMed ID: 22057187
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.
    Adam R.
    Ann Oncol; 2003 Apr 09; 14 Suppl 2():ii13-6. PubMed ID: 12810452
    [Abstract] [Full Text] [Related]

  • 20. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.